tradingkey.logo
tradingkey.logo
Suchen

Evolent Health Inc

EVH
Zur Watchlist hinzufügen
5.710USD
-0.030-0.52%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
642.25MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Evolent Health Inc Unternehmen

Evolent Health, Inc. is a health care company connecting care for people with complex conditions like cancer, cardiovascular disease, and musculoskeletal diagnoses. The Company offers three primary solutions: specialty care management services, total cost of care management and administrative services. It provides comprehensive quality management for oncology and cardiology patients from diagnosis through advanced care planning services, as well as identifying quality, lowest cost of care for outpatient orthopedic surgeries. Its total cost of care management solution enables providers to manage populations they may be accountable for under value-based contracts with payers or accountable care organizations (ACO) contracts with Centers for Medicare and Medicaid Services (CMS). Its administrative services solution includes an integrated value-based care platform designed to help customers manage and administer patient health in a cost-effective manner.

Evolent Health Inc Informationen

BörsenkürzelEVH
Name des UnternehmensEvolent Health Inc
IPO-datumJun 05, 2015
CEOBlackley (Seth)
Anzahl der mitarbeiter4500
WertpapierartOrdinary Share
GeschäftsjahresendeJun 05
Addresse1812 North Moore St, Suite 1705
StadtARLINGTON
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl22209
Telefon15713896000
Websitehttps://www.evolent.com/
BörsenkürzelEVH
IPO-datumJun 05, 2015
CEOBlackley (Seth)

Führungskräfte von Evolent Health Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Seth Blackley
Mr. Seth Blackley
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
557.56K
+7.50%
Mr. John Paul Johnson
Mr. John Paul Johnson
Chief Strategy Officer
Chief Strategy Officer
193.34K
+4.57%
Mr. Peter J. Grua
Mr. Peter J. Grua
Independent Director
Independent Director
123.74K
+33.21%
Mr. Richard M. Jelinek
Mr. Richard M. Jelinek
Independent Chairman of the Board
Independent Chairman of the Board
107.53K
+38.22%
Ms. Kim Keck
Ms. Kim Keck
Independent Director
Independent Director
102.60K
+40.06%
Mr. Craig A. Barbarosh
Mr. Craig A. Barbarosh
Independent Director
Independent Director
95.03K
+43.24%
Dr. Toyin Ajayi, M.D.
Dr. Toyin Ajayi, M.D.
Independent Director
Independent Director
75.17K
+54.67%
Mr. Shawn M. Guertin
Mr. Shawn M. Guertin
Director
Director
63.08K
+65.15%
Mr. Aammaad Shams
Mr. Aammaad Shams
Chief Accounting Officer
Chief Accounting Officer
49.35K
-12.26%
Mr. Jonathan D. Weinberg, J.D.
Mr. Jonathan D. Weinberg, J.D.
General Counsel
General Counsel
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Seth Blackley
Mr. Seth Blackley
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
557.56K
+7.50%
Mr. John Paul Johnson
Mr. John Paul Johnson
Chief Strategy Officer
Chief Strategy Officer
193.34K
+4.57%
Mr. Peter J. Grua
Mr. Peter J. Grua
Independent Director
Independent Director
123.74K
+33.21%
Mr. Richard M. Jelinek
Mr. Richard M. Jelinek
Independent Chairman of the Board
Independent Chairman of the Board
107.53K
+38.22%
Ms. Kim Keck
Ms. Kim Keck
Independent Director
Independent Director
102.60K
+40.06%
Mr. Craig A. Barbarosh
Mr. Craig A. Barbarosh
Independent Director
Independent Director
95.03K
+43.24%

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Evolent Health Inc?

Die fünf größten Anteilseigner von Evolent Health Inc sind: Mr. Seth Blackley

Wie viele Institutionen halten Anteile an Evolent Health Inc (EVH)?

Mit Stand vom 2026Q1 halten 599 Institutionen Anteile an Evolent Health Inc, mit einem Gesamtmarktwert von etwa 123.18M, was 109.51% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -49582925.00 gestiegen.

Was ist die größte Einnahmequelle von Evolent Health Inc?

Am 2026Q1 erzielte das Geschäft mit Platform and operations für Evolent Health Inc den höchsten Umsatz in Höhe von 896.75M, was 98.77% des Gesamtumsatzes entspricht.